Eman Hamam advances cell therapy engineering and regenerative medicine, developing biomaterials, microcarriers and nanoplatforms, and preconditioning strategies to enhance cell survival and targeted delivery, plus molecular biomarkers for urologic oncology and drug-induced organ toxicity.